Liang-Tsai Hsiao

Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B

Yi‐Hsiang Huang, Liang-Tsai Hsiao, Ying-Chung Hong et al. · Journal of Clinical Oncology · 2013 · 327 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system

Chun‐Yu Liu, Muh‐Hwa Yang, Shu-Chiung Chiang et al. · Thrombosis and Haemostasis · 2012 · 112 citations

Medicine, Oncology, Cancer Epidemiology +14

N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data

Peng-Chan Lin, Ming-Yang Lee, Wei-Shu Wang et al. · Supportive Care in Cancer · 2006 · 111 citations

Medicine, Oncology, Pharmacology +15

Extended Lamivudine Therapy against Hepatitis B Virus Infection in Hematopoietic Stem Cell Transplant Recipients

Liang-Tsai Hsiao, Tzeon-Jye Chiou, Chiau-Jun Chu et al. · Biology of Blood and Marrow Transplantation · 2006 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma

Yu-Chung Huang, Chia‐Jen Liu, Chun‐Yu Liu et al. · Annals of Hematology · 2011 · 42 citations

Medicine, Immunology, Internal Medicine +12